
Bear of the Day: AstraZeneca (AZN)
Published on November 26, 2021
A recent acquisition dinged this biopharma's bottom line, but is renewed growth right around the corner?

A recent acquisition dinged this biopharma's bottom line, but is renewed growth right around the corner?